Avalon Ventures XI, L.P.

Insider Reports History

Entity
Company
Location
1134 Kline Street, La Jolla, CA
Signature
Avalon Ventures XI, L.P., By: Avalon Ventures XI GP, LLC, its general partner, By /s/ Jay B. Lichter, Authorized Signatory
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Avalon Ventures XI, L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Janux Therapeutics, Inc. 10%+ Owner Common Stock 2.79M $141M $50.61 Oct 16, 2024 By Avalon BioVentures SPV I, LP
Janux Therapeutics, Inc. 10%+ Owner Common Stock 2.12M $94.7M $44.75 Oct 18, 2024 By Avalon BioVentures SPV I, L.P.
Janux Therapeutics, Inc. 10%+ Owner Common Stock 2.07M $92.7M $44.75 Oct 18, 2024 Direct
Janux Therapeutics, Inc. 10%+ Owner Common Stock 401K $18M $44.75 Oct 18, 2024 By Avalon BioVentures I, LP
Janux Therapeutics, Inc. 10%+ Owner Stock Option (right to buy) 6.07K Oct 17, 2024 Direct

Insider Reports Filed by Avalon Ventures XI, L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
JANX Janux Therapeutics, Inc. Oct 16, 2024 33 -$77.3M 4 Oct 18, 2024 10%+ Owner
JANX Janux Therapeutics, Inc. Sep 26, 2024 30 -$14.4M 4 Sep 30, 2024 10%+ Owner
JANX Janux Therapeutics, Inc. Sep 10, 2024 9 -$21.2M 4 Sep 12, 2024 10%+ Owner
JANX Janux Therapeutics, Inc. Sep 6, 2024 12 -$10.1M 4 Sep 10, 2024 10%+ Owner
JANX Janux Therapeutics, Inc. Jun 3, 2024 3 -$82.1M 4 Jun 5, 2024 10%+ Owner
JANX Janux Therapeutics, Inc. Feb 29, 2024 9 $0 4 Mar 4, 2024 10%+ Owner
JANX Janux Therapeutics, Inc. Nov 13, 2023 1 $4.99M 4 Nov 13, 2023 10%+ Owner
JANX Janux Therapeutics, Inc. Jun 15, 2021 11 $10.7M 4 Jun 16, 2021 10%+ Owner
JANX Janux Therapeutics, Inc. Jun 10, 2021 0 $0 3 Jun 10, 2021 10%+ Owner